4 completed, 3 terminated, 1 withdrawn. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 4, Terminated 3, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Rt-Pcr: new trials by email Literature Review of Rt-Pcr trials Research Report on Rt-Pcr
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia laboratory biomarker analysis, western blotting, gene expression analysis - Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2010-12-01 | 2014-01-13 | |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy panobinostat, fluorouracil, leucovorin calcium - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Terminated | University of Southern California | 7 | 2010-10-01 | 2015-05-27 |
| Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 45 | 2010-06-01 | 2020-11-16 |
| 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes 5-fluoro-2-deoxycytidine, tetrahydrouridine, laboratory biomarker analysis - Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes | Phase 1 | Completed | City of Hope Medical Center | 25 | 2009-12-22 | 2026-10-16 |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2009-04-01 | 2022-08-01 |
| Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy Ad5-CMV-NIS, Liothyronine Sodium, Reverse Transcriptase Polymerase Chain Reaction - Prostate Cancer | Phase 1 | Terminated | Mayo Clinic | 8 | 2008-11-03 | 2026-07-22 |
| Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma DI-Leu16-IL2 immunocytokine, rituximab, flow cytometry - Anaplastic Large Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 9 | 2008-03-17 | 2026-10-23 |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 29 | 2006-03-01 | 2015-04-01 |
Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Fallopian Tube Neoplasms (1) · Intraocular Lymphoma (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Liposarcoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Prostatic Neoplasms (1) · Rectal Neoplasms (1) · Sarcoma (1)
City of Hope Medical Center (3) · Roswell Park Cancer Institute (2) · Case Comprehensive Cancer Center (1) · Mayo Clinic (1) · University of Southern California (1)
United States (7)
Asher Chanan-Khan (1) · Brian J. Davis, M.D. (1) · Ehsan Malek, MD (1) · Frederic Reu (1) · Heinz-Josef Lenz (1) · Kunle Odunsi (1) · Robert Chen, MD (1) · Ryotaro Nakamura (1) · Warren Chow (1)
P50CA091956 (1), P50CA107399 (1)